FIGURE

Fig. 8

ID

ZDB-FIG-240411-26

Publication

Liu et al., 2024 - Targeting CD38/cyclic ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment

Other Figures

All Figure Page

Back to All Figure Page

Fig. 8

ZGS II, BA, and DMA induce myeloid differentiation by activating Ca2+ signaling. (A) Flow cytometry analysis of intracellular Ca2+ expression in NB4 cells treated with ZGSⅡ (10 μM), BA (10 μM), DMA (10 μM), or C3G (40 μM) for 5 days. (B) The histogram shows the mean fluorescent intensity (MFI) of intracellular Ca2+ as indicated by Fluo-4 AM staining in NB4 cells. (C) The expression of cADPR in NB4 cells with different treatments for 5 days. (D) The expression of NAD+ in NB4 cells with different treatments for 5 days. (E, F) Western blot analysis (E) and quantification (F) of IFN-γ expression in NB4 cells treated with ZGSⅡ (10 μM), BA (10 μM), DMA (10 μM), or RR (1.2 μM) for 5 days. (G) Flow cytometry analysis of CD11b expression in NB4 cells treated with ZGSⅡ, BA, DMA, or RR for 5 days. (H) The histogram shows the percentage of CD11b+ cells for each group. Data represent the mean ± SD of three independent experiments. * * P < 0.01 and * **P < 0.001 versus the corresponding control groups (one-way analysis of variance). RR: Ruthenium red.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmacol. Res.